Want to see FR:GDS full AI Analyst Report?
GDS Stock Chart & Stats
€9.34
€0.00(0.00%)
At close: 4:00 PM EST
€9.34
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€8.72 - €11.55
Previous CloseN/A
Volume15.00
Average Volume (3M)31.35K
Market Cap
€1.21B
Enterprise Value€5.07B
Total Cash (Recent Filing)€216.20M
Total Debt (Recent Filing)€4.00B
Price to Earnings (P/E)―
Beta0.25
Next Earnings
Aug 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.50
Shares Outstanding110,389,690
10 Day Avg. Volume445
30 Day Avg. Volume31,348
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)1.06
Price to Sales (P/S)0.23
P/FCF Ratio2.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Free Cash Flow GrowthA 25.21% free cash flow growth rate indicates the business converts operations into cash effectively. Durable cash generation supports reinvestment in facilities, debt servicing and operational resilience, reducing dependence on external financing over a multi‑month horizon.
Stable Revenue From Hospital NetworkOperating a diversified network of private hospitals and clinics creates recurring, reimbursement‑driven revenue streams. Tied to statutory and complementary insurers, this business model provides structural demand stability and predictable activity-based cash flows over months to years.
Efficient Cost Structure (strong Gross Margin)A strong gross profit margin shows the core clinical services generate healthy spread before overheads. This structural efficiency gives management room to improve operating leverage and absorb cost pressures, supporting margin sustainability if volumes remain stable.
Bears Say
Negative Profitability (net Losses)Persistent negative net margin and returns mean the company is not translating revenue into bottom-line profits. Over several months, continued losses can erode equity, limit reinvestment capacity, and necessitate corrective measures or capital injections to restore profitability.
High LeverageA high debt-to-equity position raises structural financial risk: interest and principal schedules constrain cash available for operations and investment. In a capital‑intensive hospital network, elevated leverage reduces flexibility to respond to sustained demand or reimbursement changes.
Cash Flow Not Yet Converting To ProfitAlthough cash generation is strong, the disconnect between free cash flow and accounting profitability implies non‑cash or financial costs (e.g., interest, impairments) are depressing earnings. This structural divergence can mask underlying profitability weaknesses over several months.
Ramsay Generale de Sante News
GDS FAQ
What was Ramsay Generale de Sante SA’s price range in the past 12 months?
Ramsay Generale de Sante SA lowest stock price was €8.72 and its highest was €11.55 in the past 12 months.
What is Ramsay Generale de Sante SA’s market cap?
Ramsay Generale de Sante SA’s market cap is €1.21B.
When is Ramsay Generale de Sante SA’s upcoming earnings report date?
Ramsay Generale de Sante SA’s upcoming earnings report date is Aug 20, 2026 which is in 15 days.
How were Ramsay Generale de Sante SA’s earnings last quarter?
Currently, no data Available
Is Ramsay Generale de Sante SA overvalued?
According to Wall Street analysts Ramsay Generale de Sante SA’s price is currently Overvalued.
Does Ramsay Generale de Sante SA pay dividends?
Ramsay Generale de Sante SA pays a Semiannually dividend of €0.791 which represents an annual dividend yield of N/A. See more information on Ramsay Generale de Sante SA dividends here
What is Ramsay Generale de Sante SA’s EPS estimate?
Ramsay Generale de Sante SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ramsay Generale de Sante SA have?
Ramsay Generale de Sante SA has 110,389,690 shares outstanding.
What happened to Ramsay Generale de Sante SA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Ramsay Generale de Sante SA?
Currently, no hedge funds are holding shares in FR:GDS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Ramsay Generale de Sante SA
Ramsay Générale de Santé S.A., headquartered in Paris, France, manages a network of hospitals across the nation. These facilities provide a wide spectrum of healthcare services, including specialized care in anesthesia, oncology, cardiology, dermatology, gastroenterology, gynecology, maternity, nephrology, neurosurgery, obesity management, ophthalmology, orthopedics, stomatology, pneumonology, psychiatry, radiology, and urology. Furthermore, they conduct various surgical procedures such as thoracic, vascular, and endovascular interventions. Founded in 1987, the company adopted its current name in December 2015, having previously been known as Générale de Santé SA. Ramsay Générale de Santé S.A. functions as a subsidiary of Ramsay Health Care Limited.